Myriam Curet
CIK 1632901 · EVP & Chief Medical Officer · last filed 2026-07-01
Myriam Curet is an EVP & Chief Medical Officer who has filed 151 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for STXS, was dated Jul 1, 2026. Across all open-market trades the lifetime net is −$89.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.23M
4
151
-$89.35M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STXS | Director | 435,161 | $1.28 | $557.0K | $0 | 10 | 2026-07-01 |
| INSP | Director | 6,927 | $51.97 | $360.0K | $188 | 5 | 2026-05-04 |
| ISRG | EVP & Chief Medical Officer | 514 | $361.80 | $186.0K | -$89.24M | 100 | 2026-03-11 |
| NKTR | Director | 1,828 | $70.77 | $129.4K | -$109.2K | 8 | 2023-09-20 |
Recent Filings
151 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-01 | STXS | Grant (A) | +43,103 | $0 | EDGAR |
| 2026-05-04 | INSP | Grant (A) | +3,562 | $0 | EDGAR |
| 2026-04-27 | ISRG | Notice (144) | −30,417 | -$14.32M | EDGAR |
| 2026-03-11 | ISRG | Mixed | — | -$27.8K | EDGAR |
| 2026-03-10 | ISRG | Notice (144) | −105 | -$51.9K | EDGAR |
| 2026-03-03 | ISRG | Notice (144) | −4,728 | -$2.30M | EDGAR |
| 2026-03-03 | ISRG | Mixed | −4,728 | -$2.34M | EDGAR |
| 2026-03-02 | ISRG | Notice (144) | −125 | -$61.6K | EDGAR |
| 2026-03-02 | ISRG | Mixed | +2,383 | -$3.51M | EDGAR |
| 2026-02-27 | ISRG | Notice (144) | −2,345 | -$1.17M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.